• NEW
    Tech Launch Perspective
    July 22, 2026

    Life sciences enterprises are moving beyond isolated generative AI pilots toward governed, multi-agent workflows that support clinical, commercial, and real-world activities. This shift is increasing demand for platforms that combine regulatory-grade data governance, enterprise interoperability, scalable…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Aug. 29, 2025

    I’ve been closely following the trajectory of Fault-Tolerant Quantum Computing (FTQC), and what we’re seeing at Everest Group is clear: the technology is maturing faster than most executives realize. Our recent research, The Quantum Leap: Innovations Driving…
  • May 07, 2025

    If there’s one technology that has captured the imagination of futurists and tech enthusiasts as much as generative AI, it’s quantum computing. The buzz is deafening – promises of breakthroughs in encryption, pharmaceuticals, and financial modeling…
  • Blog
    July 15, 2024

    One of the questions enterprise CIOs ask us at Everest Group is how they can anticipate when quantum computers will impact their competitive capabilities. Quantum computers have the ability to perform complex calculations at unprecedented speeds.…